Clinical Trial Update: Real-world Dapagliflozin Experience in Patients With Heart Failure in Greece

View source ↗

Summary

Real-world observational update on the use of dapagliflozin in patients with heart failure in Greece. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure | Status: COMPLETED